Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 November 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 192 pages)

 

Export 4 results:
Author Title Type [ Year(Asc)]
Filters: Author is Faillie, J. L.  [Clear All Filters]
2018
D. Abrahami, Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., Platt, R. W., Bouganim, N., and Azoulay, L., “Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study”, Bmj, vol. 363, p. k4880, 2018.
2016
J. L. Faillie, Yu, O. H., Yin, H., Hillaire-Buys, D., Barkun, A., and Azoulay, L., “Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus”, JAMA Intern Med, vol. 176, pp. 1474-1481, 2016.
2015
J. L. Faillie, Filion, K. B., Patenaude, V., Ernst, P., and Azoulay, L., “Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes”, Diabetes Obes Metab, vol. 17, pp. 379-85, 2015.
2014
J. L. Faillie, Azoulay, L., Patenaude, V., Hillaire-Buys, D., and Suissa, S., “Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study”, Bmj, vol. 348, p. g2780, 2014.
[Page last reviewed 4 November 2019]